Previously, the upregulation of CXCR4, a receptor of stromal derived factor (SDF/ CXCL12), has been reported as functionally crucial for the maintenance of stemness in drug-resistant NSCLC cells [13,45]. This evidence concerns the gene CXCL12 and non-small cell lung carcinoma.